Baader Bank set a €123.00 ($139.77) target price on Bayer (FRA:BAYN) in a research report report published on Wednesday morning. The firm currently has a buy rating on the healthcare company’s stock.

Several other analysts also recently commented on the stock. Nord/LB set a €98.00 ($111.36) target price on shares of Bayer and gave the stock a neutral rating in a report on Monday, June 4th. Independent Research set a €95.00 ($107.95) target price on shares of Bayer and gave the stock a neutral rating in a report on Monday, August 13th. Sanford C. Bernstein set a €120.00 ($136.36) target price on shares of Bayer and gave the stock a buy rating in a report on Monday, July 16th. UBS Group set a €130.00 ($147.73) target price on shares of Bayer and gave the stock a buy rating in a report on Thursday, June 7th. Finally, Warburg Research set a €120.00 ($136.36) target price on shares of Bayer and gave the stock a neutral rating in a report on Thursday, May 3rd. Ten equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Bayer presently has an average rating of Buy and an average target price of €109.65 ($124.60).

Shares of BAYN stock opened at €81.91 ($93.08) on Wednesday. Bayer has a 52 week low of €91.58 ($104.07) and a 52 week high of €123.82 ($140.70).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Featured Story: Technical Analysis of Stocks and What It Means

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.